BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9686602)

  • 1. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937.
    Ragg SJ; Kaga S; Berg KA; Ochi A
    J Immunol; 1998 Aug; 161(3):1390-8. PubMed ID: 9686602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle.
    Pyne S; Chapman J; Steele L; Pyne NJ
    Eur J Biochem; 1996 May; 237(3):819-26. PubMed ID: 8647130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein.
    Biggs JR; Ahn NG; Kraft AS
    Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of sphingolipid-stimulated extracellular signal regulated kinase-2 in airway smooth muscle.
    Pyne S; Pyne NJ
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):917-23. PubMed ID: 8645177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine.
    Jarvis WD; Fornari FA; Auer KL; Freemerman AJ; Szabo E; Birrer MJ; Johnson CR; Barbour SE; Dent P; Grant S
    Mol Pharmacol; 1997 Dec; 52(6):935-47. PubMed ID: 9415703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway.
    Pumiglia KM; Decker SJ
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):448-52. PubMed ID: 9012803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cells.
    Ohmori M; Shirasawa S; Furuse M; Okumura K; Sasazuki T
    Cancer Res; 1997 Nov; 57(21):4714-7. PubMed ID: 9354428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells.
    Nakamura K; Shirai T; Morishita S; Uchida S; Saeki-Miura K; Makishima F
    Exp Cell Res; 1999 Aug; 250(2):351-63. PubMed ID: 10413589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
    Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
    Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells.
    Herrera R; Hubbell S; Decker S; Petruzzelli L
    Exp Cell Res; 1998 Feb; 238(2):407-14. PubMed ID: 9473349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells.
    Conway A; Pyne NJ; Pyne S
    Cell Signal; 2000 Dec; 12(11-12):737-43. PubMed ID: 11152959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited role of ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release.
    Medvedev AE; Blanco JC; Qureshi N; Vogel SN
    J Biol Chem; 1999 Apr; 274(14):9342-50. PubMed ID: 10092612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter.
    Bonfil D; Chuderland D; Kraus S; Shahbazian D; Friedberg I; Seger R; Naor Z
    Endocrinology; 2004 May; 145(5):2228-44. PubMed ID: 14736735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A; Granot Y; Isakov N
    J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
    Hartkamp J; Troppmair J; Rapp UR
    Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.